Last year, FDA advisors unanimously voted that oral phenylephrine is ineffective.

oral phenylephrine:

“three large, carefully designed studies were conducted—two by Merck for the treatment of seasonal allergies and one by Johnson & Johnson for the treatment of the common cold. All three found no significant difference between phenylephrine and a placebo.”